Probiotics in primary prevention of allergic disease - Follow-up at 8-9 years of age

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 8, 2013, Pages 1015-1020

  West, C E ^a   Hammarstrom M L ^a   Hernell, O ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

allergy prevention; asthma; eczema; Lactobacillus paracasei ssp paracasei F19; nitric oxide

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; LACTOBACILLUS PARACASSEI F19; NITRIC OXIDE; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECZEMA; FEMALE; FOLLOW UP; FOOD ALLERGY; HUMAN; INTESTINE FLORA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRICK TEST; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSITIZATION; SPIROMETRY;

ALLERGY PREVENTION; ASTHMA; ECZEMA; LACTOBACILLUS PARACASEI SSP PARACASEI F19; NITRIC OXIDE;

CEREALS; CHILD; COLONY COUNT, MICROBIAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; INFANT; LACTOBACILLUS; MALE; PRIMARY HEALTH CARE; PROBIOTICS; SWEDEN;

EID: 84883154738     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12191     Document Type: Article

References (35)

1. West CE, D'Vaz N, Prescott SL,. Dietary immunomodulatory factors in the development of immune tolerance. Curr Allergy Asthma Rep 2011; 11: 325-333.
2. Vael C, Desager K,. The importance of the development of the intestinal microbiota in infancy. Curr Opin Pediatr 2009; 21: 794-800.
3. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC,. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012; 129: 434-440, 40 e1-2.
4. Wang M, Karlsson C, Olsson C, Adlerberth I, Wold AE, Strachan DP, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008; 121: 129-134.
5. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Muller G, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011; 128: 646-652. e1-5.
6. Brandtzaeg P,. The gut as communicator between environment and host: immunological consequences. Eur J Pharmacol 2011; 668 (Suppl 1): S16-S32.
7. Tsuji NM, Kosaka A,. Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol 2008; 29: 532-540.
8. Prescott SL, Björkstén B,. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007; 120: 255-262.
9. Verhasselt V,. Oral tolerance in neonates: from basics to potential prevention of allergic disease. Mucosal Immunol 2010; 3: 326-333.
10. West CE, Hammarström ML, Hernell O,. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20: 430-437.
11. West CE, Hernell O, Andersson Y, Sjöstedt M, Hammarström ML,. Probiotic effects on T-cell maturation in infants during weaning. Clin Exp Allergy 2012; 42: 540-549.
12. Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a World Allergy Organization position paper. World Allergy Organ J 2012; 5: 148-167.
13. West CE, Prescott SL,. Prebiotics and probiotics in prevention of allergic disease. In:, Basedow D,. (editor), UptoDate, Waltham, MA, 2013. Available at: www.uptodate.com. Last accessed 10 January 2013.
14. Kalliomäki M, Salminen S, Poussa T, Isolauri E,. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021.
15. Jensen MP, Meldrum S, Taylor AL, Dunstan JA, Prescott SL,. Early probiotic supplementation for allergy prevention: Long-term outcomes. J Allergy Clin Immunol 2012; 130: 1209-1211.
16. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123: 335-341.
17. van der Aa LB, van Aalderen WM, Heymans HS, Henk Sillevis Smitt J, Nauta AJ, Knippels LM, et al. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 2011; 66: 170-177.
18. Chen YS, Jan RL, Lin YL, Chen HH, Wang JY,. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol 2010; 45: 1111-1120.
19. West CE, Gothefors L, Granström M, Käyhty H, Hammarström ML, Hernell O,. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol 2008; 19: 53-60.
20. Rönmark E, Lundbäck B, Jonsson E, Platts-Mills T,. Asthma, type-1 allergy and related conditions in 7- and 8-year-old children in northern Sweden: prevalence rates and risk factor pattern. Respir Med 1998; 92: 316-324.
21. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
23. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
24. Björneholm S, Eklöw A, Saarela M, Mättö J,. Enumeration and identification of Lactobacillus F19. Microb Ecol Health Dis 2002; 14 (Suppl 3): 7-13.
25. Rönmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundbäck B,. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 2009; 124: 357-363, 63 e1-15.
26. Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden N, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64: 1349-1358.
27. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118: 511-521.
28. Håkansson S, Källen K,. Caesarean section increases the risk of hospital care in childhood for asthma and gastroenteritis. Clin Exp Allergy 2003; 33: 757-764.
29. Johansson MA, Sjögren YM, Persson JO, Nilsson C, Sverremark-Ekström E,. Early colonization with a group of Lactobacilli decreases the risk for allergy at five years of age despite allergic heredity. PLoS ONE 2011; 6: e23031.
30. Penders J, Thijs C, Mommers M, Stobberingh EE, Dompeling E, Reijmerink NE, et al. Intestinal lactobacilli and the DC-SIGN gene for their recognition by dendritic cells play a role in the aetiology of allergic manifestations. Microbiology 2010; 156: 3298-3305.
31. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R,. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121: e850-e856.
32. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E,. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869-1871.
33. Kukkonen AK, Kuitunen M, Savilahti E, Pelkonen A, Malmberg P, Mäkela M,. Airway inflammation in probiotic-treated children at 5 years. Pediatr Allergy Immunol 2011; 22: 249-251.
34. Wickens K, Black P, Stanley TV, Mitchell E, Barthow C, Fitzharris P, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012; 42: 1071-1079.
35. Hernell O, West CE,. Clinical effects of probiotics: scientific evidence from a paediatric perspective. Br J Nutr 2013; 109 (Suppl 2): S70-S75.